A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.

E. Lucchi, N. Minicuci, F. Magnifico, S. Mondini, A. Calza, S. Avanzi, D. Villani, G. Bellelli, M. Trabucchi

Research output: Contribution to journalArticle

Abstract

The improvement in cognitive performances due to cholinesterase inhibitors (ChEls) is not homogeneous among Alzheimer's disease (AD) subjects. Aim of this study is to evaluate whether a specific pattern of change in mini mental state examination (MMSE) could be observed in AD subjects after 9-month treatment with ChEls. From September 2000 to September 2002, 99 subjects enrolled in the CRONOS project. They have never been previously treated with ChEls. All of them completed both the 3- and the 9-month follow-up. The multidimensional assessment included MMSE, activity of daily living (ADL), instrumental activity of daily living (IADL), somatic health status, according to design of the CRONOSproject. The MMSE was analyzed both as a total score and disaggregated in 11 items. All subjects were divided in 2 groups according to the degree of change in MMSE total score from baseline to the 9th month. Subjects with a change 0 as responders (R). At start, no statistically significant differences were found between the 2 groups. MMSE score was significantly higher in the R group both at 3 (p <0.0001) and 9 months (p <0.0001), while functional status (ADL and IADL) was significantly lower in NR group at 9 months (p = 0.025; p =0.018, respectively). In MMSE qualitative analysis of 3-month, NR significantly worsened in temporal (p

Original languageEnglish
Pages (from-to)253-263
Number of pages11
JournalArchives of gerontology and geriatrics. Supplement
Issue number9
Publication statusPublished - 2004

Fingerprint

Cholinesterase Inhibitors
Activities of Daily Living
Alzheimer Disease
Health Status

Cite this

A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors. / Lucchi, E.; Minicuci, N.; Magnifico, F.; Mondini, S.; Calza, A.; Avanzi, S.; Villani, D.; Bellelli, G.; Trabucchi, M.

In: Archives of gerontology and geriatrics. Supplement, No. 9, 2004, p. 253-263.

Research output: Contribution to journalArticle

Lucchi, E, Minicuci, N, Magnifico, F, Mondini, S, Calza, A, Avanzi, S, Villani, D, Bellelli, G & Trabucchi, M 2004, 'A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.', Archives of gerontology and geriatrics. Supplement, no. 9, pp. 253-263.
Lucchi, E. ; Minicuci, N. ; Magnifico, F. ; Mondini, S. ; Calza, A. ; Avanzi, S. ; Villani, D. ; Bellelli, G. ; Trabucchi, M. / A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors. In: Archives of gerontology and geriatrics. Supplement. 2004 ; No. 9. pp. 253-263.
@article{31084371b30242f7ae28f9be07274a79,
title = "A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.",
abstract = "The improvement in cognitive performances due to cholinesterase inhibitors (ChEls) is not homogeneous among Alzheimer's disease (AD) subjects. Aim of this study is to evaluate whether a specific pattern of change in mini mental state examination (MMSE) could be observed in AD subjects after 9-month treatment with ChEls. From September 2000 to September 2002, 99 subjects enrolled in the CRONOS project. They have never been previously treated with ChEls. All of them completed both the 3- and the 9-month follow-up. The multidimensional assessment included MMSE, activity of daily living (ADL), instrumental activity of daily living (IADL), somatic health status, according to design of the CRONOSproject. The MMSE was analyzed both as a total score and disaggregated in 11 items. All subjects were divided in 2 groups according to the degree of change in MMSE total score from baseline to the 9th month. Subjects with a change 0 as responders (R). At start, no statistically significant differences were found between the 2 groups. MMSE score was significantly higher in the R group both at 3 (p <0.0001) and 9 months (p <0.0001), while functional status (ADL and IADL) was significantly lower in NR group at 9 months (p = 0.025; p =0.018, respectively). In MMSE qualitative analysis of 3-month, NR significantly worsened in temporal (p",
author = "E. Lucchi and N. Minicuci and F. Magnifico and S. Mondini and A. Calza and S. Avanzi and D. Villani and G. Bellelli and M. Trabucchi",
year = "2004",
language = "English",
pages = "253--263",
journal = "Archives of gerontology and geriatrics. Supplement",
issn = "0924-7947",
publisher = "Elsevier BV",
number = "9",

}

TY - JOUR

T1 - A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.

AU - Lucchi, E.

AU - Minicuci, N.

AU - Magnifico, F.

AU - Mondini, S.

AU - Calza, A.

AU - Avanzi, S.

AU - Villani, D.

AU - Bellelli, G.

AU - Trabucchi, M.

PY - 2004

Y1 - 2004

N2 - The improvement in cognitive performances due to cholinesterase inhibitors (ChEls) is not homogeneous among Alzheimer's disease (AD) subjects. Aim of this study is to evaluate whether a specific pattern of change in mini mental state examination (MMSE) could be observed in AD subjects after 9-month treatment with ChEls. From September 2000 to September 2002, 99 subjects enrolled in the CRONOS project. They have never been previously treated with ChEls. All of them completed both the 3- and the 9-month follow-up. The multidimensional assessment included MMSE, activity of daily living (ADL), instrumental activity of daily living (IADL), somatic health status, according to design of the CRONOSproject. The MMSE was analyzed both as a total score and disaggregated in 11 items. All subjects were divided in 2 groups according to the degree of change in MMSE total score from baseline to the 9th month. Subjects with a change 0 as responders (R). At start, no statistically significant differences were found between the 2 groups. MMSE score was significantly higher in the R group both at 3 (p <0.0001) and 9 months (p <0.0001), while functional status (ADL and IADL) was significantly lower in NR group at 9 months (p = 0.025; p =0.018, respectively). In MMSE qualitative analysis of 3-month, NR significantly worsened in temporal (p

AB - The improvement in cognitive performances due to cholinesterase inhibitors (ChEls) is not homogeneous among Alzheimer's disease (AD) subjects. Aim of this study is to evaluate whether a specific pattern of change in mini mental state examination (MMSE) could be observed in AD subjects after 9-month treatment with ChEls. From September 2000 to September 2002, 99 subjects enrolled in the CRONOS project. They have never been previously treated with ChEls. All of them completed both the 3- and the 9-month follow-up. The multidimensional assessment included MMSE, activity of daily living (ADL), instrumental activity of daily living (IADL), somatic health status, according to design of the CRONOSproject. The MMSE was analyzed both as a total score and disaggregated in 11 items. All subjects were divided in 2 groups according to the degree of change in MMSE total score from baseline to the 9th month. Subjects with a change 0 as responders (R). At start, no statistically significant differences were found between the 2 groups. MMSE score was significantly higher in the R group both at 3 (p <0.0001) and 9 months (p <0.0001), while functional status (ADL and IADL) was significantly lower in NR group at 9 months (p = 0.025; p =0.018, respectively). In MMSE qualitative analysis of 3-month, NR significantly worsened in temporal (p

UR - http://www.scopus.com/inward/record.url?scp=5444262687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5444262687&partnerID=8YFLogxK

M3 - Article

C2 - 15207422

SP - 253

EP - 263

JO - Archives of gerontology and geriatrics. Supplement

JF - Archives of gerontology and geriatrics. Supplement

SN - 0924-7947

IS - 9

ER -